New products are live, and we’ve lowered prices across the catalog. Free overnight shipping on orders over $200.

Lab Notes

Quiet week

Weekly Research Update · September 14, 2026

INDUSTRY UPDATE

Sep 7–14 was quiet on primary sources. We found no new peer-reviewed study and no new U.S. trial posting for BPC-157, TB-500, GHK-Cu, MOTS-c, SS-31/elamipretide, Semax, Selank, CJC-1295, ipamorelin, tesamorelin, sermorelin, or AOD-9604.

What circulated was older work. UCLA Health posted a Sep 9–10 Q&A on six popular research peptides. It is not new data. It recaps a review first published Aug 11 in the American Journal of Sports Medicine (Tewari et al.) covering BPC-157, TB-500, CJC-1295, ipamorelin, GHK-Cu, and MK-677. Authors’ take: animal work mixed-to-promising; human evidence thin; not a substitute for standard orthopedic care. A press recap is not an efficacy claim. Research-use only. Lot-matched COAs remain the operational standard.

PRODUCT SPOTLIGHT

GHK-Cu Research Pen

GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine. Researchers study it in copper-tripeptide chemistry and extracellular-matrix signaling models. Live SKU: 50 mg total content in a 3 mL ready-to-use research pen (≈16.67 mg/mL), clear blue solution, third-party tested with COA available. Shop: https://palmbeach-vitality.store/product/ghk-cu-pen/ — laboratory research use only.

Also flagged outside the weekly window: ClinicalTrials.gov NCT07803250 (posted Sep 3), University of Arkansas BPC-157 pilot after rotator cuff repair. Not yet recruiting. Estimated start January 2027. Registry listing only — not results.

GHK-Cu pen · 50 mg · 3 mL ready-to-use · ≈16.67 mg/mL

COA available · Research use only

RECENT RESEARCH & SCIENCE LINKS

All products are intended strictly for research use only — not for human consumption, diagnostic, or therapeutic purposes.

Research Peptides · Verified Purity · COA Documentation